Nisa Investment Advisors
COGT icon

Nisa Investment Advisors’s Cogent Biosciences COGT Stock Holding History

Nisa Investment Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Sell
3,773
-2,042
-35% -$71.4K ﹤0.01% 1372
2026
Q1 		$224K Buy
5,815
+3,960
+213% +$146K ﹤0.01% 1179
2025
Q4 		$65.9K Buy
1,855
+488
+36% +$13.7K ﹤0.01% 1556
2025
Q3 		$19.6K Buy
1,367
+10
+0.7% +$118 ﹤0.01% 2003
2025
Q2 		$9.74K Buy
1,357
+100
+8% +$554 ﹤0.01% 2279
2025
Q1 		$7.53K Sell
1,257
-106
-8% -$831 ﹤0.01% 2167
2024
Q4 		$10.6K Buy
1,363
+100
+8% +$997 ﹤0.01% 2120
2024
Q3 		$13.6K Buy
1,263
+53
+4% +$516 ﹤0.01% 2032
2024
Q2 		$10.2K Buy
1,210
+115
+11% +$872 ﹤0.01% 2147
2024
Q1 		$7.36K Buy
1,095
+40
+4% +$247 ﹤0.01% 2082
2023
Q4 		$6.2K Sell
1,055
-770
-42% -$5.9K ﹤0.01% 2103
2023
Q3 		$17.8K Buy
1,825
+771
+73% +$9.14K ﹤0.01% 2054
2023
Q2 		$12.5K Buy
1,054
+1,046
+13,075% +$12K ﹤0.01% 2220
2023
Q1 		$0 Hold
8
– – ﹤0.01% 2560
2022
Q4 		$0 Sell
8
-42
-84% -$520 ﹤0.01% 2601
2022
Q3 		$1K Buy
+50
New +$685 ﹤0.01% 2402

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nisa Investment Advisors's COGT Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Cogent Biosciences (COGT) stake by 35% in Q2 2026, selling an estimated $71.4K and leaving 3,773 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

Nisa Investment Advisors first reported a position in COGT in Q3 2022 and has held it in 16 quarters since. The position peaked at $224K in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Nisa Investment Advisors held 3,773 shares of Cogent Biosciences worth $146K as of Q2 2026.
  • Nisa Investment Advisors sold 2,042 Cogent Biosciences shares in Q2 2026, an estimated $71.4K.
  • Cogent Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1372 holding.
  • Nisa Investment Advisors first reported a position in Cogent Biosciences in Q3 2022 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Cogent Biosciences position peaked at $224K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.